Brief: Dicot To Carry Out Rights Issue Of SEK 210 Million
28/04/2026 07:38
April 28 (Reuters) - Dicot Pharma AB DICOT.ST: INTENDS TO CARRY OUT AN 80% ALREADY SECURED RIGHTS ISSUE OF SEK 210 MILLION INTENDS RIGHTS ISSUE OF UNITS TOTALING ABOUT SEK 210 MILLION WARRANT EXERCISE PRICE INTENDED AT 100–150 PERCENT OF ISSUE SUBSCRIPTION PRICE WARRANTS INTENDED TO BE EXERCISABLE DURING Q2 2027 Source text: ID:nMFN6B3dBt Further company coverage: DICOT.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Dicot Pharma AB
See all newsBrief: Dicot Pharma Recruits Cecilia Driving As CFO
Brief: Dicot Pharma Gets FDA Clearance To Start First Part Of Phase 2B Study With Lib-01 In U.S.
Brief: Dicot Pharma Announces Outcome In Oversubscribed Rights Issue
Brief: Dicot Pharma Announces Prelim Rights Issue Outcome
Brief: Dicot Pharma Submits IND Application To FDA